Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8027280 | 0.82 | TSHR (0.37) | TSHRTDP1MAPK1 | |
| SCHEMBL872202 | 0.73 | TSHR (0.33) | TSHRTDP1 | |
| SCHEMBL1104685 | 0.71 | — | — | |
| SCHEMBL2326056 | 0.71 | — | — | |
| SCHEMBL28917891 | 0.71 | — | — | |
| SCHEMBL7882792 | 0.71 | — | — | |
| SCHEMBL19865074 | 0.71 | LMNA (0.32) | TSHRTDP1 | |
| SCHEMBL20878365 | 0.71 | MAPK1 (0.33) | MAPK1 | |
| SCHEMBL17117517 | 0.71 | — | — | |
| SCHEMBL15671757 | 0.71 | TDP1 (0.35) | TSHRTDP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11073522-B2 | Structural validation of very long chain dicarboxylic acids | Lincoln Memorial University (US) | 2021-07-27 | — | — | US | disclosed |
| CN-112204697-A | Structure verification of very long chain dicarboxylic acids | 林肯纪念大学 | 2021-01-08 | — | — | CN | disclosed |
| US-20190339277-A1 | Structural Validation of Very Long Chain Dicarboxylic Acids | Lincoln Memorial University | 2019-11-07 | — | — | US | disclosed |
| US-8518988-B2 | Polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphthalenyl) ester | CHEMI SPA (IT) | 2013-08-27 | — | — | US | disclosed |
| US-20120302633-A1 | NOVEL POLYMORPH OF THE HYDROCHLORIDE OF THE (4-HYDROXYCARBAMOYL-PHENYL)-CARBAMIC ACID (6-DIMETHYLAMINO METHYL-2-NAPHTHALENYL) ESTER | CHEMI SPA (IT) | 2012-11-29 | — | — | US | disclosed |
| WO-2011092556-A1 | NOVEL POLYMORPH OF THE HYDROCHLORIDE OF THE (4-HYDROXYCARBAMOYL-PHENYL)-CARBAMIC ACID (6-DIMETHYLAMINO METHYL-2-NAPHTALENYL) ESTER | CHEMI SPA (IT) | 2011-08-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120302633-A1 | NOVEL POLYMORPH OF THE HYDROCHLORIDE OF THE (4-HYDROXYCARBAMOYL-PHENYL)-CARBAMIC ACID (6-DIMETHYLAMINO METHYL-2-NAPHTHALENYL) ESTER | H1-4, CRYAA, NPM1 | TSHR 3308/4885TDP1 357/4885MAPK1 2119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.